Insulin glargine, KwikPen 100 [iU] / mL Injection 3 mL (Basaglar, KwikPen)
Comprehensive product details for sourcing and verification.
| NDC 11 | 00002-7715-59 |
|---|---|
| Product NDC | 00002-7715 |
| Generic Drug Name | Insulin glargine, KwikPen |
| Brand Name | Basaglar, KwikPen |
| Manufacturer | Eli Lilly and Company |
| Strength | 100 [iU] / mL |
| Dosage Form | Injection |
| Drug Type | Subcutaneous |
| Package Quantity | 5 Syringe |
| Package Description | 5 SYRINGE in 1 CARTON (0002-7715-59) / 3 mL in 1 SYRINGE (0002-7715-01) |
| Active Ingredients | Insulin Glargine |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Insulin glargine, KwikPen 100 [iU] / mL Injection is tracked under NDC 00002-7715-59 and rolls up into product family 00002-7715. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 5 Syringe.
- Manufacturer: Eli Lilly and Company.
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Public sources show a secondary shortage summary for Basaglar/insulin glargine and official FDA shortage context.
Drug Shortage Index family
View Insulin glargine-yfgn in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Insulin glargine-yfgn.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Insulin glargine, KwikPen 100 [iU] / mL Injection 3 mL (Basaglar, KwikPen), NDC 00002-7715-59, is a Eli Lilly and Company 100 [iU] / mL injection presentation packaged as 5 Syringe. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00002-7715-59.
- Digits-only NDC 11: 00002771559.
- Possible 10-digit display format: 0002-7715-59 (0002771559).
Helpful product links
- Search by brand name: Basaglar, KwikPen.
- Exact NDC 11: 00002-7715-59.
- Product family NDC: 00002-7715.
- Other package sizes in this family: 1 Syringe.
- Compare related presentations: Insulin glargine, KwikPen 100 [iU] / mL Injection 3 mL (Basaglar, KwikPen).
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.